Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
7-Point Dermoscopy ChecklistABSI (Burn Severity)AGEP ScoreAJCC Melanoma StagingALDEN AlgorithmBWH SCC StagingBody Surface Area (BSA)Breslow & Clark MicrostagingCTCAE Skin ToxicityDLQIEASI ScoreGAGS (Acne)HiSCRIGAIHS4Lund-Browder ChartMSK Melanoma NomogramMelanoma Risk ScreeningPASI ScorePOEMRegiSCAR DRESS ValidationRevised Baux ScoreSCORADmPASI
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

In Recent Clinical News

Scanning Medical Journals

No new significant updates or guidelines matching this topic were found today. We will check again soon.

ALDEN Algorithm

ALden Algorithm: Determines the probability that Allopurinol is the culprit drug in SJS/TEN.

Culprit Factors

Time from Drug Intake to Reaction
Daily Dosage of Allopurinol
Other Suspect Drugs Present?

Awaiting Analysis

Enter the medication timeline and dosage details to evaluate the probability of Allopurinol causality.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use

ALDEN (Algorithm of Drug Causality for Epidermal Necrolysis) is applied per-drug in a patient with confirmed Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN) to determine which medication(s) among all those the patient is taking are most likely responsible. It is specifically designed for the SJS/TEN context — with timing windows, dechallenge and rechallenge weights calibrated to the distinctive immunopathology of epidermal necrolysis.

Appropriate Application

Confirmed SJS (< 10% TBSA epidermal detachment) or TEN (> 30%) or SJS/TEN overlap (10–30%)
Applied independently to every drug the patient was taking at or before the index day (day of first skin symptom)
Used to prioritize drug discontinuation when polypharmacy is present
Used to guide definitive allergy documentation and family genetic counseling post-episode
Academic/epidemiological case investigation for pharmacovigilance

When NOT to Use

AGEP, DRESS, or other SCARs (ALDEN timing/weighting is calibrated specifically to SJS/TEN)
As a substitute for immediate drug discontinuation — stop all non-essential drugs first, then calculate
When the "index day" cannot be reliably established — score validity depends on this anchor

Related Scores in Practice

In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the SCORTEN, AGEP Score or the RegiSCAR DRESS Validation to formulate a comprehensive care plan.

Last Comprehensive Review: 2026

Related Dermatology Tools

Body Surface Area
BWH SCC Staging
GAGS
IHS4
mPASI
AJCC Melanoma Staging
DLQI
Revised Baux Score
IGA
POEM
Dermatology CalculatorsInternal Medicine CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.